Detalhe da pesquisa
1.
Stated preferences of physicians and chronic pain sufferers in the use of classic strong opioids.
Value Health
; 15(1): 106-17, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22264978
2.
Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Value Health
; 14(6): 800-11, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21914499
3.
A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals.
HIV Clin Trials
; 11(2): 80-99, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20542845
4.
Cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico.
Value Health
; 13(8): 903-14, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21091827
5.
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
BMC Neurol
; 9: 6, 2009 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208243
6.
Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.
Pharmacoeconomics
; 26(3): 217-34, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18282016
7.
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.
Chest
; 124(2): 526-35, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12907538
8.
Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Cancer
; 109(6): 1082-9, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17265519
9.
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
Value Health
; 10(2): 98-116, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17391419
10.
The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
Vaccine
; 25(39-40): 6900-10, 2007 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-17764790
11.
Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
Value Health
; 8(1): 10-23, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15841890